Literature DB >> 9398720

Cytokine production by a new undifferentiated human thyroid carcinoma cell line, FB-1.

L Fiore1, L E Pollina, G Fontanini, R Casalone, M T Berlingieri, R Giannini, F Pacini, P Miccoli, A Toniolo, A Fusco, F Basolo.   

Abstract

A human anaplastic thyroid cancer cell line FB-1, derived from a 68-yr-old woman who underwent surgery for anaplastic thyroid cancer, has been established. The spindlelike cells have been proliferating stably for more than 2 yr. Karyotype analysis shows many abnormalities and many marker chromosomes have been observed. Heterotransplant of FB-1 cells into severe combined immunodeficient mice has resulted in rapidly growing tumors classified as anaplastic carcinomas, although 50% have shown areas with a trabecular pattern. FB-1 cells failed to express messenger RNA for thyroglobulin; TSH-receptor; thyroperoxidase, and placental angiogenic growth factor. Conversely, PAX8 and thyroid transcription factor 1, whose expression is thyroid specific, was kept in an FB-1 cell line at a level comparable with that observed in normal thyroid tissue. In addition, the present cell line expressed high levels of messenger RNA for high-mobility group proteins (Y) and -C. The in vitro study revealed that FB-1 cells are able to produce high levels of interleukin (IL)-8 and medium amount of IL-6, whereas no release of IL-1-alpha, IL-1-beta, and IL-4 was observed. No modulation of cell proliferation and DNA synthesis in FB-1 cells has been observed after the addition of exogenous IL-6.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9398720     DOI: 10.1210/jcem.82.12.4444

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Establishment and characterization of a human thyroid carcinoma cell line (HOTHC) producing colony stimulating factor.

Authors:  Isamu Ishiwata; Isao Ono; Kazushige Kiguchi; Chieko Ishiwata; Masayuki Soma; Hiroshi Ishikawa
Journal:  Hum Cell       Date:  2005-09       Impact factor: 4.174

2.  Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias.

Authors:  S Scala; G Portella; M Fedele; G Chiappetta; A Fusco
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

3.  CD133+ anaplastic thyroid cancer cells initiate tumors in immunodeficient mice and are regulated by thyrotropin.

Authors:  Susan Friedman; Min Lu; Atara Schultz; Dolly Thomas; Reigh-Yi Lin
Journal:  PLoS One       Date:  2009-04-30       Impact factor: 3.240

4.  BRAF Inhibitors Induce Feedback Activation of RAS Pathway in Thyroid Cancer Cells.

Authors:  Elisa Bonaldi; Chiara Gargiuli; Loris De Cecco; Arianna Micali; Maria Grazia Rizzetti; Angela Greco; Maria Grazia Borrello; Emanuela Minna
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 6.208

5.  UbcH10 overexpression may represent a marker of anaplastic thyroid carcinomas.

Authors:  P Pallante; M T Berlingieri; G Troncone; M Kruhoffer; T F Orntoft; G Viglietto; A Caleo; I Migliaccio; M Decaussin-Petrucci; M Santoro; L Palombini; A Fusco
Journal:  Br J Cancer       Date:  2005-08-22       Impact factor: 7.640

6.  Highly selective toxic and proapoptotic effects of two dimeric ribonucleases on thyroid cancer cells compared to the effects of doxorubicin.

Authors:  D Spalletti-Cernia; R Sorrentino; S Di Gaetano; R Piccoli; M Santoro; G D'Alessio; P Laccetti; G Vecchio
Journal:  Br J Cancer       Date:  2004-01-12       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.